Washington State regulators are accepting public comments on a proposal to a create process allowing marijuana businesses to document their participation in the medical cannabis market in order to ease their access to benefits that come with the Trump administration’s partial rescheduling move.
The Liquor and Cannabis Board (LCB) voted last week to move ahead with the plan, which is based on an advocacy group’s petition and comes after state officials said earlier this year that rescheduling cannabis on the federal level “does not appear to apply” to businesses in Washington.
Under an order issued by Attorney General Todd Blanche in April, marijuana products regulated by a state medical cannabis license immediately moved from Schedule I of the Controlled Substances Act (CSA) to Schedule III, as did any marijuana products that are approved by the Food and Drug Administration (FDA).
While an administrative hearing is considering broader marijuana rescheduling, Washington businesses currently have no way to verify their medical cannabis-specific activities.
“Rules on this subject may be needed to consider the development and operation of a certification program for licensees participating in licensed medical cannabis activity in the state,” LCB said in an update after the vote. “This certification would serve
Read full article on Marijuana Moment
